Search results for: 'drive tech eu'

This study focuses on emerging pharmacological and non-pharmacological strategies in the treatment of obesity, as well as evolving new paradigms for the future. It describes the contribution of incretin-based therapies, particularly GLP-1 receptor agonists and their multi-agonist counterparts, which provide robust effects on weight loss and metabol...

17 Nov 2020  |  North America  |  Market Research

Business Models Focusing on Patient Centricity Driving Incremental Value in the Global Digital Patient Engagement Solutions Market, 2025

Growth Strategies to Revolve Around Value-based Care and Population Health Management Initiatives

Infographics

×

Healthcare is evolving, more so after the Coronavirus 2019 (COVID-19) pandemic that hit us in the beginning of 2020. Over time, we have seen surveys that indicate that patients want more control of their healthcare and be active participants of their treatment decisions. Innovations in technology and recent developments in the healthcare ecosystem ...

Biological age tracking is emerging as a complementary approach to understanding human health, offering a more nuanced assessment of physiological state than chronological age alone. This report examines the evolving landscape of biological aging platforms, with a focus on molecular and omics-based technologies including epigenetic, proteomic, tran...

21 May 2021  |  North America  |  Market Research

Explosion of Data Drives the US Social Determinants of Health Market

Proven Returns on Investment will Ignite Transformational Growth

Infographics

×

This report from Frost & Sullivan Healthcare and Life Sciences focuses on the potential to cater to healthcare needs based on data-driven social determinants of health (SDOH). Although the traditional practice of healthcare involves the use of medical technology and protocols to maintain and restore health, the SDOH concept adds another dimension. ...

Clinical-grade wearables are regulatory-approved devices that provide clinically actionable data for monitoring, diagnostic, and therapeutic applications. As demand for continuous remote monitoring of patients increases to mitigate healthcare challenges, such as rising costs and staff shortages, so will the potential for wearable devices to support...

31 Jan 2022  |  North America  |  Market Research

Global Digital Health Investments Growth Opportunities

On-demand Healthcare Services and AI-enabled Care Delivery Enable Future Growth Potential

Infographics

×

Frost & Sullivan observed a significant increase in the digital transformation of healthcare and demand for effective IT solutions to improve care delivery, creating a lot of excitement among investors. Venture capitalist activities in health technology rise as healthcare organizations, clinical trial providers, insurance firms, employers, and poli...

Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...

12 May 2025  |  Global  |  Market Research

Clinical Decision Support System Market, Global, 2024–2030

AI Integration is Driving Transformational Growth by Enabling Improvements in Clinical Outcomes

Infographics

×

The increasing focus on effective population health management is prompting healthcare organizations to adopt next-generation clinical decision support tools that drive market growth. Healthcare systems continue to face significant clinical quality and efficiency challenges, leading to a heightened focus on implementing clinical decision support sy...

As the industry continues to innovate across novel small- and large-molecule therapies, including RNA-targeted small molecules, cell and gene therapies, and mRNA therapies, pharma sponsors increasingly rely on partners for technology access, database generation and analysis, and preclinical and clinical research.These disruptions continue to drive ...